Search Results
CRDN RAREsummit19 - Patient Groups in Drug Development
CRDN RAREsummit19: Disruptive Innovation & Transformation: Patients and the drug development process
CRDN RAREsummit19 Disruptive technologies – Patients at the heart of AI
CRDN RAREsummit19 Keynote Address by Alastair Kent OBE
How Rare Disease Patient Groups Can Work With Pharma - Speaker 3
CRDN RAREsummit19 - Baroness Nicola Blackwood - We Need a National Conversation on Rare Disease
CRDN RAREsummit19 - "Peer-led to get Ahead" - by Laurence Woollard, On the Pulse Consultancy
Drug Repurposing for Rare Diseases Scientific Conference - Dr Daniel O'Connor & Johnathan Underhill
Policy Development and Patient Engagement for Rare Disease with Alistair Kent
Dr Emma Davies - Artificial Intelligence research
CSAR: Dr Jonathan Milner
Amicus Therapeutics Uses BlueJeans' Collaboration tools to Develop Life Changing Medicine
